Launch date is coming Up. Maxrale China Pharma Holdings (NYS...

Launch date is coming Up. Maxrale
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.

China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.